<DOC>
	<DOCNO>NCT01555762</DOCNO>
	<brief_summary>This multicenter , prospective , observational study evaluate efficacy safety Avastin ( bevacizumab ) first-line therapy elderly patient metastatic colorectal cancer . Data collect eligible patient for24 month .</brief_summary>
	<brief_title>An Observational Study Avastin First Line Elderly Patients With Metastatic Colorectal Cancer ( CASSIOPEE )</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adult patient , &gt; /= 75 year age Metastatic colorectal cancer Initiating Avastin firstline therapy combination chemotherapy Previous Avastin therapy Patient participate clinical study evaluate cytotoxic anticancer therapy and/or investigational new drug</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>